Pharma

sponsor

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Human Genome Sciences, Inc. announced that it expects to have top-line results available on Monday, July 20, from BLISS-52, the first of two pivotal Phase 3 clinical trials of BENLYSTA in systemic lupus erythematosus (SLE).

Today in Conferences/Meetings...keeping you current

Covidien plc to Report First-Quarter Results on January 2010
Covidien, 12/17/09

ONC to Explain Community I.T. Project
HealthDataManagement, 12/17/09

MediGene AG presents future business plan at annual analyst conference
MediGene, 12/16/09